Literature DB >> 18706433

Fentanyl treatment reduces GABAergic inhibition in the CA1 area of the hippocampus 24 h after acute exposure to the drug.

E Kouvaras1, E K Asprodini, I Asouchidou, A Vasilaki, T Kilindris, D Michaloudis, I Koukoutianou, C Papatheodoropoulos, G Kostopoulos.   

Abstract

The effect of in vivo fentanyl treatment on synaptic transmission was studied in the CA1 area of the rat hippocampus. Animals were treated either with saline or fentanyl (4 x 80 microg/kg, s.c./15 min). Intracellular in vitro recordings were obtained, 24 h after treatment, from CA1 pyramidal neurons. No difference in pyramidal neuron basic membrane properties or postsynaptic membrane excitability was observed between neurons from saline- and fentanyl-treated animals. The peak amplitude of fast (f-) and slow (s-) components of IPSPs elicited in standard ACSF and the peak amplitude and rate of rise of isolated f- and s-IPSPs elicited in the presence of antagonists (CNQX, 10 microM; AP-5, 10 microM; CGP 55845, 1 microM; and bicuculline methochloride, 10 microM), in response to various stimulus intensities, was smaller in fentanyl-treated animals. Conversely, the rising slope of excitatory responses was similar in neurons from saline- and fentanyl-treated animals. Furthermore, in fentanyl-treated animals, lower stimulus strengths were required to elicit subthreshold excitatory responses of the same amplitude suggesting that acute exposure to fentanyl increases susceptibility of pyramidal neurons to presynaptic stimulation. GABA immunohistochemistry revealed lower GABA content in processes and neuronal somata suggesting diminished GABA release onto pyramidal neurons. We conclude that acute in vivo exposure to fentanyl is sufficient to induce long-lasting reduction in GABA-mediated transmission, rather, than enhanced excitatory transmission or modulation of the intrinsic excitability of pyramidal neurons. These findings provide evidence regarding the mechanisms involved in the early stages of tolerance development towards the analgesic effects of opioids.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18706433     DOI: 10.1016/j.neuropharm.2008.07.025

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  5 in total

1.  Sensory encoding in Neuregulin 1 mutants.

Authors:  Claudia S Barz; Thomas Bessaih; Ted Abel; Dirk Feldmeyer; Diego Contreras
Journal:  Brain Struct Funct       Date:  2014-12-17       Impact factor: 3.270

Review 2.  Anaesthesia for deep brain stimulation: a review.

Authors:  Ryan Grant; Shaun E Gruenbaum; Jason Gerrard
Journal:  Curr Opin Anaesthesiol       Date:  2015-10       Impact factor: 2.706

Review 3.  Noradrenergic Mechanisms in Fentanyl-Mediated Rapid Death Explain Failure of Naloxone in the Opioid Crisis.

Authors:  Randy Torralva; Aaron Janowsky
Journal:  J Pharmacol Exp Ther       Date:  2019-09-06       Impact factor: 4.030

4.  Phosphorylated CaMKII levels increase in rat central nervous system after large-dose intravenous remifentanil.

Authors:  Qiang Wang; Xin Zhao; Shuren Li; Song Han; Zhifeng Peng; Junfa Li
Journal:  Med Sci Monit Basic Res       Date:  2013-04-02

5.  Effect of acute fentanyl treatment on synaptic plasticity in the hippocampal CA1 region in rats.

Authors:  Hai Tian; Yueming Xu; Fucun Liu; Guowei Wang; Sanjue Hu
Journal:  Front Pharmacol       Date:  2015-10-30       Impact factor: 5.810

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.